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Abstract 
Objective: This study was aimed to compare the efficacy among chronic 
asthma patients who received 1 course treatment, 2 courses treatment and 3 
courses treatment of Tianjiu Therapy in Sanfu Days. Methods: This study was 
comparing efficiency with 3 courses (baseline, the 1st course, the 2nd course, 
the 3rd course) of Tianjiu Therapy for asthma in 91 chronic asthma patients. 
For each course, patients received 3 times Tianjiu Therapy treatments, pre-
treatment assessment and posttrestment assessment. Results: 91 asthma par-
ticipants completed at least 3 courses of Tianjiu Therapy in Sanfu Days. 1) 
Days for asthma attacked during the last 12 months; the frequency for asthma 
attacked during the last 12 months; incidence of admitting to clinic (Inte-
grated Chinese Medicine & Western Medicine Clinic) when asthma attack 
during the last 12 months; times of admitting to clinic; times of solving by 
persistent medicine; times of solving by own medicine when asthma attack 
during the last 12 months; and symptoms associated with Chinese medicine of 
waking by asthma symptoms, lack of strength, lassitude, rapid or difficult 
breathing were improved at the 1st course, the 2nd course and the 3rd course 
compared with baseline (All P < 0.05); 2) The incidence of admitting to 
In-patient Hospital and solving by persistent prescription when asthma at-
tacked; the frequency of Chinese Herbal Medicine used during Tianjiu Ther-
apy; the status of asthma under controlled and no improved by self-evaluation 
were similarly improved at the 2nd course and the 3rd course (All P < 0.05); 
3) Incidence of admitting to A & E for asthma attacked during the last 12 
months, and other treatments except Western Medicine, Chinese Herbal 
Medicine, and Acupuncture & Moxibution during the last 12 months were 
improvement at the 3rd course (All P < 0.05); 4) Symptoms associated with 
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Chinese medicine of spontaneous sweating and reduction of exercise were 
improved at the 1st course (P < 0.05); 5) Symptom of diarrhea after intake of 
oil food was became a little bad at the 2nd course and the 3rd course (P < 
0.05); 6) The frequency of bronchodilator used when asthma attack was re-
duced in the 1st course and the 2nd course (All P < 0.05); 7) Lung function of 
FEV1 and FEV1/FVC(×100) were a little improvement, but have no signifi-
cant statistical difference (P > 0.05); 8) The total score of ACT at the 1st 
course, the 2nd course, and the 3rd course did not improved significantly (All 
P > 0.05). Conclusion: After Tianjiu Therapy in Sanfu Days participants have 
achieved good efficiency, and as the course get longer, the efficiency of more 
symptoms associated with chronic asthma were improved. Suggest patients 
with chronic asthma continuous receive Tianjiu Therapy in Sanfu Days which 
will be a feasible treatment. 
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1. Introduction 
Bronchial asthma is a chronic airway inflammatory disease, which belongs to 
“asthma disease” of the Traditional Chinese Medicine [1], performance of 
breathing difficulties, even open mouth and carry up shoulder. Western Medi-
cine for the treatment of asthma, β2-adrenoceptor agonist are the first-line drug 
for diastolic bronchospasm, mainly stay on the stage of focusing on the applica-
tion of glucocorticoid to prevent airway remodeling stage, but glucocorticoids 
are still not fully meet the clinical needs [2]. It has a long history in the struggle 
with asthma disease of Traditional Chinese Medicine (TCM). 
Modern research proved, acupoint sticking could enhance the body’s 
non-specific immune function and function of pituitary-adrenal cortex system, 
reduce the body’s allergic condition, achieve the effect of anti-allergic, and could 
remove bronchospasm and promote exudate absorption directly, so as to relieve 
asthma attack [3]. Tianjiu Therapy is sticking external specific acupoints and 
trouble place by certain Chinese medicine and trouble place, make local hyper-
emia, blister, or even fester, like post-moxibustion sore to treat disease , it is a 
kind of unti-hot moxibustion therapy [4]. Sanfu Days are the highest tempera-
ture days through a year, start from summer solstice, according to the arrange-
ment of Heavenly Stems and Earthly Branches, the third Geng-ri is the first Fu 
Day, the forth Geng-ri is the second Fu Day, and the first Geng-ri after the be-
ginning of autumn is the last Fu Day. Tianjiu Therapy in Sanfu Days for asthma 
follows the rule of the external treatment to cure internal disease and the me-
thods of curing winter disease in summer of TCM. Tianjiu Therapy in Sanfu 
Days has a very special characteristic of medical timing of treatment therapy, on 
Sanfu Days, Positive-qi of nature and human body is most strongest in the year, 
stick herbal cake made up of some medicine with the feature of spicy and hot, 
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stimulating on the acupuncture point, to achieve the purpose of regulating Yin 
and Yang, preventing and curing of disease through the function of both acu-
puncture point stimulation and drug infiltration absorption. It is widely used in 
the treatment of asthma and other cold symptoms because the operation is sim-
ple, safe and reliable, lasting for many years in the clinical curative effect [5]. In 
recent years, with the deepening study, Tianjiu Therapy in Sanfu Days has got 
great progress with asthma controlled. Now it was widely applied in the clinical 
treatment of asthma as the curative effect of Tianjiu Therapy was widely recog-
nized, and more and more people are receive this treatment method for preven-
tion and treatment of asthma [6]-[14]. We have already conducted an initial trail 
which compared 1 year of Tainjiu Therapy treatment with placebo control 
group, and a clinical trial which compared two years versus 1 year Tianjin 
Therapy in Sanfu Days for chronic asthma [15] [16]. In the first study, it was 
found that Tianjiu Therapy can reduce the need for medications to control 
asthma, improved the low quality of life with asthma patients; In the second 
study, it was proved that the effect of 2 years Tianjiu Therapy was not as effective 
as 1 year such treatment for asthma, but the second year Tianjiu Therapy was 
still need because it has a role to consolidate the curative effect of Tianjiu Ther-
apy for asthma. In the previous two studies, the efficiency of Tianjiu Therapy in 
Sanfu Days for asthma was proved, but the optimal treatment duration is still 
unknown. Hence this study was aimed to compare the efficacy among chronic 
asthma patients who received 1 course treatment, 2 courses treatment and 3 
courses treatment of Tianjiu Therapy in Sanfu Days. 
2. Methods 
2.1. Enrollment Criteria 
Asthma patients were recruited from the Orthopedics-Traumatology, Acupunc-
ture and Tui-na Clinical Centre for Teaching and Research, School of Chinese 
Medicine, The University of Hong Kong. 
The patients are in both gender above 13 years old, and the participants must 
be diagnosed asthma before and have symptoms associated with chronic asthma 
in the past 12 months. In addition, all patients were needed to meet the follow-
ing inclusion criteria: difficulty breathing; episodic symptoms of airflow obstruc-
tion; symptoms occurring or worsening at night; symptoms awakening the pa-
tients at night; chest tightness; cough (worse at night); symptoms occurring or 
worsening with exercise, viral infections, changes in weather and strong emo-
tions. Patients would be excluded according to one or more of the following ex-
clusion criteria: acute asthma attack; fever and pharyngitis; pregnancy; severe 
cardiac and pulmonary diseases; tuberculosis; severe heart diseases or with pa-
cemaker; bleeding disorders; keloid; allergy to topical medication; hypersensitive 
skin condition; diabetes mellitus. And all patients who took part in the study 
needed to sign consent inform by themselves or their legal guardian (younger 
than 18 years old). 
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2.2. Study Design 
In this study, participants totally completed at least 3 treatment courses of Tian-
jiu Therapy in Sanfu Days, pretreatment assessment and posttreatment assess-
ment from 2010 to 2015. Every treatment course consisted 3 treatment sessions 
(3 treatment sessions were conducted in Sanfu Days in every year: for example, 
19 July, 29 July and 8 August 2010 respectively). Both pretreatment assessment 
and posttreatment assessment included pulmonary function, questionnaires, and 
ACTs. 
Baseline was set at before the first treatment course; Patients 1 year after the 
first course treatment and before the second course was set as the 1st course; Pa-
tients 1 year after the second course treatment and before the third course was 
set as the 2nd course; Patients 1 year after the third course treatment and before 
the forth course was set the 3rd course. 
All questionnaires (Table 1), ACTs (Asthma Control Test) and lung-function 
test were completed by face to face interview before every session. Patients must 
completed 3 treatment courses from 2010 to 2015 (Table 1), and they also must 
have completed all pretreatment assessments and posttreatment assessments. 
There were 48 continuous participants and 43 discontinuous participants among 
the 91 patients. This study conducted a subgroup analysis for continuous group 
and discontinuous group, but nothing different was found in most of the out-
come measurements. Hence this study combined two groups above as study 
subjects. 
The three treatment times from 2010 to 2015 were as follow: 
July19, July 29, and August 8, 2010; 
July 14, July 24, and August 13, 2011; 
July18, July 28, and August 7, 2012; 
July 13, July 23, and August 12, 2013; 
July18, July 27, and August 14, 2014; 
 
Table 1. Patients distribution. 
Year of patients completed Patients Year of patients completed Patients 
2010-2011 and 2012-2013 6 2010-2011-2012-2013-2014 5 
2010-2011 and 2012-2014 1 2010-2011-2012-2013-2015 2 
2010-2011 and 2012-2015 2 2010-2011-2012-2014-2015 1 
2010-2011 and 2013-2014 6 2010-2011-2013-2014-2015 5 
2010-2011 and 2014-2015 2 2010-2012-2013-2014-2015 3 
2010-2012 and 2013-2014 5 2010-2011-2012-2013-2014-2015 12 
2010-2013 and 2014-2015 10 2011-2013-2014-2015 3 
2011-2012 and 2013-2014 1 2011-2012-2013-2014-2015 11 
2011-2012 and 2013-2015 1   
2011-2012 and 2014-2015 4 
  
2012-2013 and 2014-2015 11 
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July 13, July 23, and August 12, 2015. 
11 acupoints were selected for attached by sticking patches: DU14, DU12, 
DU4, BL13 (both side), BL23 (both sides), BL43 (both sides) and EX-B1 (both 
sides) (Figure 1). 
The formula mixed herbs was a combination of the record in the “Zhang’s 
Medicine” and the formula was frequency used in clinical trials just now, the 
proportion was 2:1:1:1:1:1:1:1: Sinapi Alba 120g, Radix Corydalis Yanhusuo 60 g, 
Processed Euphorbia kansui 60 g, Asari Herba cum Radice 60 g, Ephedrae Herba 
60 g, Processed Radix Aconiti Praeparata 60 g, Cinnamomum cassia 60 g and 
Eugenia caryophyllata 60 g. These are for around 100 participants used. All of 
them were milled in to powder and mixed together by ginger juice, and then was 
made into pieces of cake-like objects, every piece was about 2 grams. 
Every acupoint was applied one piece of the herbs, the herbs was stuck in skin 
by approximately 4 cm × 4 cm hypoallergenic tape (3 M Micropore Tape 
1535-3). 
2.3. Outcome Measures 
Lung function included: FEV1, FEV1/FVC (%). 
ACT included: In the past 4 weeks, 1) the times of asthma keep participants 
from getting as much done at work, school or at home, and 2) the frequency of 
shortness of breath, and 3) the frequency of asthma symptoms (whee zing, 
coughing, shortness of breath, chest tightness or pain) wake up at night or earli-
er than usual in the morning, 4) the frequency of using rescue inhaler or 
 
 
Figure 1. Acupoints selected for Tianjiu Therapy in Sanfu Days. 
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nebulizer medication (such as albuterol), and 5) the rate of the asthma wad con-
trolled. Participants could fill 1-5 scores for every question. 
The questionnaire could be filled physicians “zero” when the participant wanted 
to fill “NO”, and filled “1” when they wanted to fill “YES”, For example: “Did you 
use any Western Medicine when paroxysm in the past 12 months?” if the answer is 
“YES”, then got “1” score, if the answer is “NO”, then got “0” score. 
Questionnaire included: 1) Asthma first attacked time; 2) Courses of asthma 
attacked; 3)The frequency and extent of asthma attacked in the past 12 months; 
4) Condition of bronchodilator used when asthma attacked in the past 12 
months; 5) Situation of asthma care and emergency in the past 12 months; 6) 
Treatment other than Western Medicine for asthmas in the past 12 months; 7) 
Asthma under controlled self-evaluation; 8) Cases of 23 asthma symptoms im-
proved or not in the past 12 months. 
2.4. Statistical Analysis 
Statistical analyses were performed with the Statistical Package for the Social 
Sciences (SPSS) software program (version 21) for Windows 8. 
The data analysized included baseline, the 1st course, the 2nd course, and the 3rd 
course. Lung function: FEV1, FEV1/FVC (%), and the number of days for asth-
ma signs, the number of days for using any Western Medicine were tested by 
Nonparametric tests (Friedman Test), the value of the best efficient course was 
tested by Nonparametric tests (Wilcoxon Signed Test 2 Related-Samples), de-
scription analysis was conducted for the percentage of patients with twenty- 
three symptoms associated with asthma, the percentage of asthma healthy care, 
the percentage of bronchodilator used, and the percentage of asthma attack. 
3. Results 
There are 1516 person-time with chronic asthma were recruited from 2010 to 
2015: 323 in 2010, 391 in 2011, 283 in 2012, 206 in 2013, 164 in 2014, and 149 in 
2015, among them 910 person-time completed Tianjiu Therapy (242 in 2010, 
169 in 2011, 132 in 2012, 149 in 2013, 117 in 2014, and 101 in 2015), and among 
the 910 person-time, 179 participants completed one course Tianjiu Therapy, 77 
participants completed two courses, 54 participants completed three courses, 52 
participants completed four courses, 27 participants completed five courses 
Tianjiu Therapy, 12 participants completed six courses, there were 401 partici-
pants completed at least one course Tianjiu Therapy. Patients would be excluded 
for the final statistical analysis due to the incomplete data. The cause of incom-
plete data included incomplete treatments, during treatment period participants 
illness, asthma exacerbation, losing contact, pregnancy, inability to participate 
timely, refusing to participate, did not in Hong Kong, or incomplete ACT, ques-
tionnaire, lung function test. The participants can be included for the final anal-
ysis only when they have seven time points’ data (the 1st course pre and post-as- 
sessment, the 2nd course pre and post-assessment, the 3rd course pre and post- 
assessment, the 4th course pre-assessment). Overall, from 2010 to 2015, patients 
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who received three-course Tianjiu Therapy in Sanfu Days were 91. 
For the baseline characteristics of the 91 participants, the average age was 50 ± 
15.26 (14 to 93) years old, 33% was male, 67% was female; the average onset age 
was 32.78 ± 22.99 (1 to 93) years old; and the average courses of asthma attacked 
was 19.98 ± 17.90 (1 to 93) (Table 2). 
In baseline, in the past 12 months, the number of days patients subjected 
asthma-related symptoms was: 106.49 ± 142.83, and means (± SD) of FEV1 was 
1.85 ± 0.94, and the mean ratio of FEV1 to forced vital capacity (FVC) was 81.68 
± 19.06. The percentage of participants had been hospitalized and admitted to A 
& E at least once for an asthma-related event was 22% and 15.4% respectively; 
the percentage of participants had been clinic visit and persistent prescription 
was 81.3% and 86.8% respectively; the percentage of participants had been by 
own medication was 13.2%; and the percentage of participants had not been 
processed was 9.9%; the frequency of bronchodilator never used in past 12 
months was 8.9% (Table 3). For the specific twenty-three such symptoms: pa-
tients suffered: 1. wind intolerance was 27.9%; 2. susceptible to cold was 27%; 3. 
sneeze, running nose before onset was 22.5%; 4. onset during quarter turn was 
29.3%; 5. rapid or difficult breathing was 18.4%; 6. wake up by asthma symptoms 
was 24.7%; 7. bluish complexion was 37.5%; 8. spontaneous sweating was 26.8%; 
9. Lassitude was 9.5%; 10. lack of speech was 12%; 11. decline in physical 
strength was 13%; 12. reduction of exercise was 24.1%; 13. lack of strength was 
28.4%; 14. lack of energy after asthma was 23.3%; 15. poor appetite was 29.2%; 
16. abdomen fullness was 29.4%; 17. sloopy stool was 35%; 18. diarrhea after in-
take of oily food was 37.5%; 19. fear of cold was 25.7%; 20. soreness and weak-
ness of waist and was 28.4%; 21. tinnitus was 28.6%; 22. frequent urination/night 
was 33.3%; 23. redness, hotness was 33.3% (Table 4). 
3.1. Response to Intervention 
3.1.1. The Incidence of Asthma Attack in the Past 12 Months 
The incidence of asthma attack in the past 12 months declined from 29.4% in 
baseline to 26.1% in the 1st course, and 21.6% in the 2nd course, and 22.9% in the 
3rd course. After treatment, the efficiency of acute asthma attack has significant 
difference among the 4 time points (P < 0.05) (Table 3), the 1st course was im-
proved (P < 0.01), the 2nd course and the 3rd course improved significant (All P < 
 
Table 2. Characteristics of Parcitipants. 
Characteristic Average 
Age—year 50 ± 15.26 
Gender—no. (%)  
Male 33 (36.30) 
Female 68 (63.70) 
Course of disease—year 19.98 ± 17.90 
Onset age 32.78 ± 22.99 
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Table 3. Characteristics of Parcitipants. 
Variable baseline The 1st course 
The 2nd 
course 
The 3rd 
course P value CI 
Acute asthma attack in past year—no. (%) 
 91 (29.4) 81 (26.1) 67 (21.6) 71 (22.9) 0.000### 21.563 
Days for asthma-related symptoms in last 12 months—(means ± SD) 
 106.49 ± 142.83 66.22 ± 110.68 42.49 ± 81.51 42.31 ± 88.82 0.000
###  
Pulmonary function test 
 1.85 ± 0.94 1.73 ± 0.67 1.92 ± 1.51 1.80 ± 0.98 0.233  
 81.68 ± 19.06 82.76 ± 14.89 83.37 ± 14.60 79.50 ± 19.17 0.221  
Asthma-related health care in last 12 months—no. (%) 
≥1 Admit to A & E 20 (22) 10 (11) 10 (11) 6 (6.6) 0.014# 10.65 
≥1 Hospitalization 14 (15.4) 7 (7.7) 4 (4.4) 3 (3.3) 0.010# 11.452 
≥1 Outpatient visit 74 (81.3) 44 (48.4) 49 (54.4) 50 (55.6) 0.000### 24.264 
≥1 Prescription 79 (86.8) 76 (83.5) 58 (63.7) 62 (68.1) 0.000### 18.926 
≥1 By own medication 12 (13.2) 12 (13.2) 6 (6.6) 7 (7.7) .0296# 3.700 
≥1Not to be proceed 9 (9.9) 10 (11) 10 (11) 8 (8.8) .0331# 0.954 
The frequency of bronchodilator during asthma attack—no. (%) 
More than twice per day 24 (27.3) 15 (17) 12 (13.6) 37 (42) 
63.257  
Once to twice per day 33 (39.3) 28 (33.3) 13 (15.5) 10 (11.9) 
Twice to three times per 
week 9 (47.4) 3 (15.8) 6 (31.6) 1 (5.3) 
Less than once per week 15 (26.3) 13 (22.8) 19 (33.3) 10 (17.5) 
Never 9 (8.9) 29 (28.7) 28 (37.6) 25 (24.8) 
#P < 0.05; #P < 0.01; ###P < 0.001. FEV1: Forced expiratory volume in one second; V1/FVC: Forced expirato-
ry volume in one second/forced vital capacity. aAccident and emergency Departments (A & E). 
 
Table 4. The twenty-three symptoms of participants’ self-evaluation. 
Symptom—no. (%)    
1. wind intolerance 14 (16.3) 13. lack of strength 16 (19.8) 
2. susceptible cold 13 (20.6) 14. lack of energy after asthma attack 9 (20.9) 
3. sneeze\running nose before onset 16 (22.5) 15. poor appetite 7 (29.2) 
4. onset during quarter 6 (8.0) 16. abdomen fullness 4 (11.8) 
5. rapid or difficult breathing 33 (26.4) 17. sloopy stool 4 (10.0) 
6. wake up by asthma symptoms 25 (29.4) 18. diarrhea after intake of oil food 2 (6.3) 
7. bluish complexion 2 (12.5) 19. fear of cold 13 (17.6 
8. spontaneous sweating 8 (19.5) 20. soreness and weakness of waist and knees 15 (20.3) 
9. lassitude 13 (20.6) 21. tinnitus 10 (20.4) 
10. lack of speech 7 (28.0) 22. frequent urination/night urination 6 (10.5) 
11. decline in physical strength 13 (24.1) 23. redness, hotness or anxiety 7 (16.7) 
12. reduction of exercise 2 (6.9)   
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0.001), and improvement in the 2nd course and the 3rd course improved similarly 
on the incidence of asthma attack in the past 12 months (P > 0.05) (Figure 2, 
Table 5). This indicated the improvement in the 2nd course and the 3rd course 
were greater than the 1st course. 
3.1.2. Days for Asthma Attacked in Past 12 Months 
Days for asthma attacked in past 12 months showed 106.49 ± 142.83 in baseline, 
and declined to 66.22 ± 110.68 in the 1st course, 42.49 ± 81.51 in the 2nd course, 
and 42.31 ± 88.82 in the 3rd course, and there was improvement of days for 
asthma attacked among baseline, the 1st course, the 2nd course and the 3rd course 
(All P < 0.05) (Table 3). Compared with baseline, the 1st course was decreased 
with the days of asthma attacked (P < 0.05); the 2nd course was decreased sharply 
with the days of asthma attacked (P < 0.01); the value of the 3rd course was de-
creased significantly (P < 0.001); the 3rd course had the most improvement, but 
the improvements among the 1st course, the 2nd course and the 3rd course were 
no statistical difference (All P > 0.05), that means the 1st course, the 2nd course 
and the 3rd course had experienced similar improvement on days for asthma at-
tacked in the past 12 months, and the 3rd course have a better improvement 
(Figure 3, Table 6). 
3.1.3. The Rate of Western Medicine Used during Asthma Attack 
After treatment, Western Medicine (bronchodilator) used during asthma at-
tacked was: 1) decreased from 27.3% in baseline to 17% in the 1st course and 
13.6% in the 2nd course, but increased to 42% in the 3rd course; 2) decreased from 
39.3% in baseline to 33.3% in the 1st course, 15.5% in the 2nd course and 11.9% in 
the 3rd course once or twice per day; 3) decreased from 47.4% in baseline to 
15.8% in the 1st course, 31.6% in the 2nd course and 5.3% in the 3rd course 
 
Table 5. The incidence of asthma attack in the last 12 months. 
Baseline & 
The 1st course 
Baseline & 
The 2nd 
course 
Baseline & 
The 3rd course 
The 1st course 
& The 2nd 
course 
The 1st course 
& The 3rd 
course 
The 2nd 
course & The 
3rd course  
−2.714b −4.796b −3.838b −3.130b −1.732b −1.091c Z value 
0.007## 0.000### 0.000### 0.002## 0.083 0.275 P value 
Noted: a. By Wilcoxon Signed Test 2 Related-Samples. b. Based on Rank. c. Based on Negative Rank. #P < 
0.05; ##P < 0.01; ###P < 0.001. 
 
Table 6. Days for asthma attack. 
Baseline & 
The 1st course 
Baseline & 
The 2nd 
course 
Baseline & 
The 3rd course 
The 1st course 
& The 2nd 
course 
The 1st course 
& The 3rd 
course 
The 2nd 
course & The 
3rd course  
−2.15 −2.95 −3.77 −.77 −1.12 −0.11 Z value 
0.031# 0.003## 0.000### 0.440 0.261 0.091 P value 
#P < 0.05; ##P < 0.01; ###P < 0.001. 
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Figure 2. The incidence of asthma attack in the last 12 months. 
 
 
Figure 3. Days for asthma attacked in last 12 months. 
 
twice or three times a week; 4) decreased from 26.3% in baseline to 22.8% in the 
1st course, 33.3% in the 2nd course and 17.5% in the 3rd course less than once per 
week; 5) increased from 8.9% in baseline to 28.9% in the 1st course, 37.6% in the 
2nd course and 24.8 % in the 3rd course that never happened. There was signifi-
cant decrease in the rate of western medicine used by asthma participants after 
treatment, and significant increase in the rate of western medicine never used by 
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asthma participants after treatment (P < 0.05) (Table 3). The 1st course im-
proved sharply (P < 0.01), the 2nd course improved significantly (P < 0.001); the 
3rd course did not improved (P > 0.05), which indicated that the 1st course and 
the 2nd course both improved, but the 2nd course improved better than the 1st 
course (P < 0.05) (Figure 4, Table 7). 
3.1.4. The Rate of Processing Method during Tianjiu Therapy When 
Asthma Attacked 
Different processing method during Tianjiu therapy when asthma attacked in-
cluded: 1) A & E admitting during Tianjiu therapy was 22% at baseline, and de-
creased to 11% at the 1st course and the 2nd course, and 6.6% at the 3rd course. 
Obviously, there was a great difference after any course of treatment, and the 
improvement have statistical difference (P < 0.05) (Table 3). Average of admit-
ting to A & E was 2.69 at baseline, and decreased to 2.47 at the 1st course and the 
2nd course, and decreased to 2.38 at the 3rd course, the 3rd course was sharply im-
proved (P < 0.01), but there was no statistical difference between 1st course and 
3rd course, 2nd course and 3rd course (All P > 0.05) (Table 8), which indicated al-
though there was no statistical difference among three courses on A & E admit-
ting during the past 12 months, there still had improvement at the 3rd course 
(Figure 5). 
2) The result showed significant statistical difference for admit to In-patient 
Hospital during Tianjiu therapy among the 4 time points (P < 0.05) (Table 3).  
 
Table 7. The rate of western medicine (bronchodilator) was used by asthma patients. 
Baseline & 
The 1st course 
Baseline & 
The 2nd 
course 
Baseline & 
The 3rd course 
The 1st course 
& The 2nd 
course 
The 1st course 
& The 3rd 
course 
The 2nd 
course & The 
3rd course  
−3.232b −5.093b −1.722b −2.105b −1.378c −3.182c Z value 
0.001## 0.000### 0.085 0.035# 0.168 0.001## P value 
 
 
Figure 4. The rate of western medicine (bronchodilator) was used by asthma patients. 
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The percentage was 15.4% at baseline, it was declined to 7.7% in the 1st course 
(P > 0.05), and 4.4% in the 2nd course (P < 0.001), and 3.3% in the 3rd course (P < 
0.01). Although there was no statistical difference between 2nd course and 3rd 
course (P > 0.05), it still indicated that 2nd course have a tendency of improving 
better than 3rd course on admitting to In-patient Hospital during Tianjiu therapy 
on Sanfu days (Table 8, Figure 6). 
3) The frequency of admitting to Integrated Chinese medicine & Western 
Medicine Clinic was 81.3% at baseline, it declined to 48.4% at 1st course, that  
 
 
Figure 5. The frequency of admitting to A & E. 
 
 
Figure 6. The frequency of admitting to hospital. 
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means the 1st course experienced significant improvement (P < 0.001); and 
54.4% at 2nd course, the 2nd course experienced deeply improvement (P < 0.01), 
and 55.6% at the 3rd course, the 3rd course experienced significant improvement 
(P < 0.001) (Table 3). But there was no tatistical difference mong 1st course, 2nd 
course and 3rd course (P > 0.05). Results showed that 3 courses have similar im-
provements on frequency of admitting to Integrated Chinese medicine & West-
ern Medicine Clinic, and there was similar tendency of improvement between 1st 
course and 3rd course (Table 8, Figure 7). 
4) The percentage of solving by persistent prescription when asthma attacked 
was 86.8% at baseline, it was declined to 83.5 at 1st course (P > 0.05), 63.7% at the 
2nd course, it means 2nd course experienced significant improvement (P < 0.001), 
and 68.1% at the 3rd course, it means 3rd course experienced sharply improve-
ment (P<0.01), but there was no statistical difference between 2nd course and 3rd 
course on solving by persistent when asthma attack (P > 0.05) (Table 8), which 
indicated that at 2nd course have a better improvement on solving by persistent 
prescription when asthma attacked (Figure 8). 
3.1.5. Times of Different Processing Method during Tianjiu Therapy 
When Asthma Attacked 
1) Times for admitting to clinic was 18.88 ± 48.404 at baseline, it was de-
creased to 4.15 ± 12.205 at 1st course (P < 0.001), 5.03 ± 15.093 at 2nd course (P < 
0.001), and 0.57 ± 0.519 at 3rd course (P < 0.001), which means that there was 
significant improvement on times for admitting to clinic (Table 8), and the im-
provements were similar among 1st course, 2nd course and 3rd course (All P > 
0.05) (Table 8, Figure 9). 
 
 
Figure 7. The frequency of admitting to Integrated Chinese Medicine & Western Medi-
cine Clinic. 
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Table 8. Analyze health care of each two courses when asthma attacked. 
 Baseline & 1st course 
Baseline & 
2nd course 
Baseline & 
3rd course 
1st course & 
2nd course 
1st course & 
3rd course 
2nd course & 
3rd course 
 
Admit to A 
& E 
−2.041d −2.041d −2.985b 0.000c −1.069d −1.155b Z value 
0.41 0.41 0.003## 1.000 0.285 0.248 P value 
Admit to 
hospital 
−1.698b −7.500c −3.051b −1.000b −1.265b −0.447b Z value 
0.090 0.000### 0.002## 0.317 0.206 0.655 P value 
Admit to 
clinic 
−4.423b −3.429b −3.773b −1.121c −1.333c −0.169c Z value 
0.000### 0.001## 0.000### 0.262 0.182 0.886 P value 
Solve by 
persistent 
medication 
−0.600b −3.550b −3.053b −3.182b −2.475b −0.649c Z value 
0.549 0.000### 0.002## 0.001## 0.013# 0.516 P value 
Times of 
admitting to 
clinic 
−3.781b −4.158b −4.211b −0.028b −0.543c −1.432c Z value 
0.000 0.000 0.000 0.978 0.587 0.152 P value 
Times of 
solving by 
persistent 
medicine 
−4.526b −4.435b −5.162b −0.304b −4.435b −0.65c Z value 
0.000 0.000 0.000 0.761 0.000 0.948 P value 
Times by 
own medica-
tion 
−3.141b −3.935b −4.226b −8.69b −3.935b −0.347b Z value 
0.001 0.000 0.000 0.385 0.000 0.729 P value 
Noted: a. Wilcoxon Signed-rank test. b. based on rank. c. based on negative rank. 
 
 
Figure 8. The frequency of solving by persistent prescription. 
 
2) Times for persistent prescription when asthma attacked was 130.03 ± 
93.349 at baseline, it was decreased to 47.63 ± 103.014 at 1st course, 64.08 ± 
175.212 at 2nd course, and 16.86 ± 93.963 at 3rd course, which means that there 
were significant statistical differences (All P < 0.05) (Table 9), but without any  
56 
Y. Y. Tan et al. 
 
 
Figure 9. Times for admitting to hospital. 
 
Table 9. Analyze health care of all courses when asthma attacked. 
Variable  
(Average/Mean ± SD) 
baseline The 1st course The 2nd course The 3rd course P value 
Times to A & E 0.51 ± 1.23 0.18 ± 0.53 1.24 ± 10.38 0.07 ± 0.25 0.339 
Times to hospital 1.41 ± 10.40 0.11 ± 0.41 0.09 ± 0.49 0.04 ± 0.21 0.227 
Times to clinic 18.88 ± 48.40 4.15 ± 12.20 5.03 ± 15.09 0.57 ± 0.52 0.002## 
Times to persistent 130.03 ± 93.35 47.63 ± 103.01 64.08 ± 175.21 16.86 ± 93.95 0.001## 
Times by own medicine 20.57 ± 39.46 4.63 ± 20.37 2.40 ± 14.59 1.42 ± 10.48 0.000### 
Times of not proceed 9.84 ± 43.96 14.60 ± 115.44 3.31 ± 19.46 1.29 ± 10.38 0.386 
 
statistical difference among 1st course, 2nd course and 3rd course (P > 0.05) (Table 
9), which means the 1st course, the 2nd course, the 3rd course experienced similar 
improvements on times for persistent prescription after Tianjiu therapy on San-
fu days (Figure 10). 
3) Times of solving by own medication was 20.57 ± 39.456 at baseline, it was 
decreased to 4.63 ± 20.372 at 1st course (P < 0.01), which indicated that the 1st 
course experienced sharply improvement; 2.40 ± 14.594 at 2nd course (P < 0.001), 
and 1.42 ± 10.483 at 3rd course (P < 0.001), which indicated that 2nd course and 
3rd course experienced significant improvement (Table 9), but there were no sta-
tistical difference between 2nd course and 3rd course (P > 0.05) (Table 9), that 
means 2nd course and 3rd course experienced similar improvement on the times 
of solving by own medication (Figure 11). 
3.1.6. The Percentage of Treatments Received When Asthma Attacked 
1) The rate of receiving Chinese Herbal Medicine when asthma attacked was 
34% at baseline, and it was decreased to 24.2% at 1st course (P > 0.05), 15.2% at 
2nd course (P < 0.001), and 23.1% at 3rd course (P < 0.01) (Table 10, Figure 13). 
Which indicated that 1st course had no improvement compared with baseline,  
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Figure 10. Times for persistent prescription. 
 
 
Figure 11. Times for times by own medication. 
 
the 2nd course experienced sharply improvement, and 3rd course experienced sig-
nificant improvement compared with baseline, but there was no statistical dif-
ference between 2nd course and 3rd course (P > 0.05) (Table 10), which means 
that the 2nd course and the 3rd course have experienced similar significant im-
provement of the rate of receiving Chinese Herbal Medicine when asthma at-
tacked, but 2nd course experienced a better improvement tendency than 3rd 
course (Figure 12). 
2) The rate of other treatments was 8.8% at baseline, and it was increased to 
30.8% at 1st course (P < 0.01), 39.1% at 2nd course (P < 0.001), and 16.5% at 3rd 
course (P > 0.05) (Table 10), which indicated participants increased to accept 
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Figure 12. The rate of Chinese Herb Medicine. 
 
Table 10. The percentage of treatments received other than Western Medicine for asth-
ma. 
—no. (%) Baseline The 1
st 
course 
The 2nd 
course 
The 3rd 
course P value X² 
Any treatments other 
than Western Medicine 
42 (46.2) 38 (41.8) 38 (41.3) 30 (33) 0.305 3.62 
Chinese Herb Medicine 34 (37.4) 22 (24.2) 14 (15.2) 21 (23.1) 0.003## 13.69 
Acupuncture &  
Moxibustion 
14 (15.4) 9 (9.9) 7 (7.6) 11 (12.1) 0.385 3.05 
Others 8 (8.8) 28 (30.8) 36 (39.1) 15 (16.5) 0.000### 24.48 
 
other treatment at 1st course and 2nd course, there was no statistical difference at 
3rd course compared with baseline (P > 0.05) (Table 10, Table 11, Figure 13). 
3.1.7. The Percentage of Asthma under Controlled 
The percentage of asthma participants under controlled was 11.9% at baseline, it 
was increased to 18.1% at 1st course (P > 0.05), 35.2% at 2nd course (P < 0.001), 
and 34.8% at 3rd course (P < 0.001) (Table 12). There were significant statistical 
differences between 1st course and 2nd course, 1st course and 3rd course (All P < 
0.05), There was no significant statistical difference between 2nd course and 3rd 
course (P > 0.05) (Table 12, Table13). The results indicated that 2nd course and 
3rd course experienced similarly percentages of asthma under controlled (Figure 
14). 
3.1.8. The Percentage of Asthma Have No Improvement after Tianjiu 
Therapy 
The percentage of asthma participants experienced no improvement was 38.6% 
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Figure 13. Other treatments than western medicine and Chinese Medicine and acupunc-
ture & moxibustion. 
 
Table 11. Treatments received when asthma attack by Wilcoxon Signed Test 2 Re-
lated-Samples. 
 
Baseline & 
The 1st 
course 
Baseline & 
The 2nd 
course 
Baseline & 
The 3rd 
course 
The 1st course & 
The 2nd course 
The 1st course 
& The 3rd 
course 
The 2nd 
course & 
3rd course  
Chinese  
herbal −2.175
b −3.781b −2.694b −2.065b −1.92b −1.886c Z value 
Medicine 0.13 0.000### 0.007## 0.039# 0.847 0.059 P value 
Other −3.182c −3.920c −8.16c −1.155c −2.030b −3.550b Z value 
treatments 0.001## 0.000### 0.414 0.248 0.040# 0.000### P value 
Noted: a. By Wilcoxon Signed Test 2 Related-Samples. b. based on rank. c. based on negative rank. 
 
Table 12. The percentage of asthma is under controlled and no improvement of 3 courses 
and baseline. 
—no. (%) Baseline The 1
st 
course 
The 2nd 
course The 3
rd course P value X² 
Asthma is under 
controlled 25 (11.9) 38 (18.1) 74 (35.2) 73 (34.8) 0.000 83.245 
No improvement 27 (38.6) 19 (27.1) 11 (15.7) 13 (18.6) 0.012 10.966 
 
at baseline, it was decreased to 21.7% at 1st course, 15.7% at 2nd course, and 
18.6% at 3rd course, and the decline of four time points has a statistical difference 
(P < 0.05) (Table 13). There was no improvement compare 1st course with base-
line (P > 0.05). There were significant statistical difference on improvement be-
tween 2nd course and baseline, 3rd course and baseline (P < 0.01), There was no  
60 
Y. Y. Tan et al. 
 
 
Figure 14. The percentage of asthma under controlled. 
 
Table 13. The percentage of asthma is under controlled by Wilcoxon Signed Test 2 Re-
lated-Samples. 
 
Baseline 
& the 
1st course 
Baseline 
& the 
2nd course 
Baseline 
& the 3rd 
course 
The 1st 
course & the 
2ndcourse 
The 1st 
course & the 
3rd course 
The 2nd course 
& the 3rd course  
No  
improvement 
−1.414b −2.828b −2.858b −1.633b −1.279b −4.71c P value 
0.157 0.005 0.004 0.102 0.201 0.637 Z value 
Under  
controlled 
−1.857b −6.607b −6.532b −5.427b −5.105b −0.200c P value 
0.063 0.000 0.000 0.000 0.000 0.841 Z value 
Noted: a. Wilcoxon Signed-rank test. b. based on rank. c. based on negative rank. 
 
improvement compare 2nd course with 3rd course (P > 0.05) (Table 12, Table 
13). The results indicated that the percentage of asthma have no improvement in 
the 2nd course and the 3rd course (Figure 15). 
3.1.9. The rate of Twenty-three Symptoms during Tianjiu Therapy 
1) Percentage of rapid or difficult breathing was 32.4% at baseline, it was de-
creased to 18.8% at 1st course, 25.8% at 2nd course, 23.0% at 3rd course, there were 
statistical difference among the baseline and the 3 courses (P < 0.05) (Table 14). 
1st course improved significantly (P < 0.001), 2nd course sharply (P < 0.01), and 
3rd course improved (P < 0.05), the 2nd course and the 3rd course similar im-
provement in the statistical (P > 0.05), that was to say the 1st course has best im-
provement in the percentage of rapid or difficult breathing during Tianjiu 
Therapy (Table 15, Figure 16). 
2) The percentage of wake up by asthma symptoms was 39.5% at baseline, it 
was decreased to 17.5% at 1st course, 22.0% at 2nd course, 20.9% at 3rd course, the 
proportions of 3 courses after treatment reduced significantly compared with 
baseline (P < 0.05) (Table 14). The percentages of the 1st course, the 2nd course, 
and the 3rd course were all improved significantly with baseline (All P < 0.001),  
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Table 14. The participants’ symptoms scale of 3 courses. 
Symptoms scale Baseline The 1
st 
course 
The 2nd 
course 
The 3rd 
course P value 
Detail symptoms—no. (%) 
1 Wind intolerance 38 (25.3) 29 (19.3) 41 (27.3) 42 (28.0) 0.19 
2 Susceptible cold 43 (31.9) 26 (19.5) 32 (23.7) 34 (25.2) 0.072 
3 Sneeze\running nose before onset 47 (26.3) 38 (21.2) 42 (23.5) 52 (29.1) 0.182 
4 Onset during quarter 58 (25.6) 49 (21.6) 64 (28.2) 56 (24.7) 0.146 
5 Rapid or difficult breathing 69 (32.4) 40 (18.8) 55 (25.8) 49 (23.0) 0.000 
6 Wake up by asthma symptoms 70 (39.5) 31 (17.5) 39 (22.0) 37 (20.9) 0.000 
7 Bluish complexion 13 (31.0) 7 (16.7) 9 (21.4) 13 (31.0) 0.406 
8 Spontaneous sweating 27 (32.9) 10 (12.2) 23 (28.0) 22 (26.8) 0.017 
9 Lassitude 53 (38.7) 25 (18.2) 26 (19.0) 33 (24.1) 0.000 
10 Lack of speech 27 (34.2) 16 (20.3) 18 (22.8) 18 (22.8) 0.195 
11 Decline in physical strength 39 (29.8) 26 (19.8) 29 (22.1) 37 (28.2) 0.135 
12 Reduction of exercise 19 (26.0) 8 (11.0) 24 (32.9) 22 (30.1) 0.015 
13 Lack of strength 58 (33.7) 37 (21.5) 36 (20.9) 41 (23.8) 0.003 
14 Lack of energy after asthma attack 25 (26.9) 15 (16.1) 26 (28.0) 27 (29.0) 0.147 
15 Poor appetite 15 (29.4) 10 (19.6) 13 (25.5) 13 (25.5) 0.762 
16 Abdomen fullness 21 (24.1) 16 (18.4) 26 (29.9) 24 (27.6) 0.33 
17 Sloopy stool 15 (20.8) 15 (20.8) 21 (29.2) 21 (29.2) 0.477 
18 Diarrhea after intake of oil food 10 (13.5) 16 (21.6) 21 (28.4) 27 (36.5) 0.014 
19 Fear of cold 38 (25.3) 34 (22.7) 37 (24.7) 41 (27.3) 0.769 
20 Soreness and weakness of  
waist and knees 48 (25.7) 41 (21.9) 53 (28.3) 45 (24.1) 0.337 
21 Tinnitus 31 (29.2) 25 (23.6) 27 (25.5) 23 (21.7) 0.623 
22 Frequent urination/night urination 30 (26.5) 21 (18.6) 35 (31.0) 27 (23.9) 0.153 
23 Redness, hotness or anxiety 24 (25.0) 18 (18.8) 27 (28.1) 27 (28.1) 0.383 
 
but the improvements among 1st course, 2nd course and the 3rd course were simi-
lar (P > 0.05) (Table 15, Figure 17). 
3) The percentage of spontaneous sweating was 32.9% at baseline, it was de-
clined to 12.2% at 1st course, 28.0% at 2nd course, 26.8% at 3rd course, the propor-
tion of 3 courses after treatment compared with baseline showed reduce signifi-
cantly (P < 0.05) (Table 14). The percentage of 1st course was statistically differ-
ent compared with baseline (P < 0.001), there were no improvement compare 2nd 
course and 3rd course with baseline (All P > 0.05) (Table 15), which indicated 
that the 1st course has improved the symptoms of spontaneous sweating (Figure 
18). 
62 
Y. Y. Tan et al. 
 
 
Figure 15. The percentages of asthma have no improvement. 
 
 
Figure 16. The percentage of rapid or difficult breathing during Tianjiu Therapy. 
 
4) The percentage of lassitude was 38.7% at baseline, decreased to 18.2% at 1st 
course, 19.0% at 2nd course, 24.1% at 3rd course, the proportion of 3 courses 
compared with baseline were significantly reduced (P < 0.05) (Table 14). The 1st 
course and the 2nd course improved significantly (All P < 0.001), and the 3rd 
course improved sharply (P < 0.01), there were no statistical difference among 1st 
course, 2nd course and 3rd course (P > 0.05) (Table 15), which indicated that 1st 
course, 2nd course and 3rd course have similar improvements with symptoms of 
lassitude, but 1st course and 2nd course have a better improvement tendency than  
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Figure 17. The percentage of waking up by asthma. 
 
Table 15. Twenty-three clinic symptoms of Chinese Medicine. 
 
Baseline & 
the 1st 
course 
Baseline & 
the 2nd 
course 
Baseline & 
the 3rd 
course 
The 1st 
course & 
the 2nd 
course 
The 1st 
course & 
the 3rd 
course 
The 2nd 
course & 
the 3rd 
course 
 
Rapid or diffi-
cult breathing 
−4.143b −2.160b −3.015b −2.402c −1.521c −1.061b Z value 
0.000### 0.031# 0.003## 0.016# 0.128 0.289 P value 
Wake up by 
asthma symp-
toms 
−5.571b −4.522b −5.032b −1.333b −1.029c −0.408b Z value 
0.000### 0.000### 0.000### 0.182 0.303 0.683 P value 
Spontaneous 
sweating 
−3.545b −0.853b −1.000b −2.711c −2.588c −0.200b Z value 
0.000### 0.394 0.317 0.007## 0.011# 0.841 P value 
Lassitude 
−4.320b −4.025b −3.244b −1.92c −1.461c −1.135c Z value 
0.000### 0.000### 0.001## 0.847 0.144 0.178 P value 
Reduce of 
exercise 
−2.294b −0.898c −0.539c −3.266c −2.746c −0.343b Z value 
0.022# 0.369 0.59 0.001## 0.006## 0.732 P value 
Lack of 
strength 
−3.452b −3.667b −2.874b −0.200b −0.707c −0.898c Z value 
0.001## 0.000### 0.004## 0.841 0.48 0.369 P value 
Diarrhea after 
intake of oily 
food 
−1.342b −2.200b −3.545b −1.147b −2.200b −1.225b Z value 
0.18 0.028# 0.000### 0.251 0.028# 0.221 P value 
Noted: a. Wilcoxon Signed-rank test. b. base on rank. c. base on negative rank. 
 
3rd course (Figure 19). 
5) The percentage of reduction of exercise was decreased from 26.0% at base-
line to 11.0% at 1st course, and increased to 32.9% at 2nd course, 30.1% at 3rd  
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Figure 18. The percentage of spontaneous sweating. 
 
course (Table 14). There were no improvement compared 2nd course and 3rd 
course with baseline (P > 0.05), but the percentage of the 1st course improved (P 
< 0.05), which indicated the 1st course have improved the symptoms of reduction 
of exercise (Table 15, Figure 20). 
6) The percentage of lack of strength was declined from 33.7% at baseline to 
21.5% at 1st course, 20.9% at 2nd course, 23.8% at 3rd course, the proportions of 4 
time points were statistical difference (P < 0.05) (Table 14). The improvements 
of 1st course and 3rd course were sharply (All P < 0.01), 2nd course was signifi-
cantly (P < 0.001), there were no statistical difference among 1st course, 2nd 
course and the 3rd course (P > 0.05), which means the improvements of 1st 
course, 2nd course and 3rd course for symptoms of participants suffering from 
lack of strength were similar, and 2nd course have a better improvement tenden-
cy (Table 15, Figure 21). 
7) The percentage of diarrhea after intake of oil food was 13.5% at baseline, it 
was increased to 21.6% at the 1st course, 28.4% at the 2nd course, 36.5% at the 3rd 
course, the improvements with proportion have statistical difference (All P < 
0.05) (Table 14). The percentages of the 2nd course and the 3rd course were sta-
tistically increased compared with baseline (All P < 0.05), there was no statistical 
difference compared baseline with the 1st course (P > 0.05), which means the 2nd 
course and the 3rd course have a little worse in symptoms of participants suffer-
ing from diarrhea after intake of oil food. (Table 15, Figure 22). 
3.1.10. Results of Lung function 
Average of FEV1 was 1.85 ± 0.94 at baseline, it was decreased to 1.73 ± 0.64 at 1st 
course, 1.73 ± 0.64 at 2nd course, increased to 1.92 ± 1.51 at 3rd course (All P > 
0.05) (Table 3), which indicated there was no significant statistical improvement  
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Figure 19. The percentage of participants suffered from lassitude. 
 
 
Figure 20. The proportion of participants suffered from reduction of exercise. 
 
after any course of FEV1 for asthma participants; The percentage of 
FEV1/FVC(×100) was 81.68 ± 19.06 in baseline, there were increased to 82.76 ± 
14.89 at 1st course, 83.37 ± 14.6 at 2nd course, and declined to 79.50 ± 19.17 at 3rd 
course (All P > 0.05) (Table 3). That means after 3 courses of Tianjiu therapy, 
there was no significant statistical improvement of FEV1/FVC for participants. 
3.1.11. Results of ACT 
The average total scores of participants was 19.55 ± 4.87 at baseline, and in-
creased to 20.55 ± 1.37 at 1st course, 20.91 ± 3.48 at 2nd course, and 21.00 ± 2.93 
at 3rd course, there was no statistical difference among the results (All P > 0.05)  
66 
Y. Y. Tan et al. 
 
 
Figure 21. The proportion of participants suffered from lack of strength. 
 
 
Figure 22. The proportion of participants suffered from Diarrhea after intake of oil food. 
 
(Table 16), which means that there was no significant improvement for the 5 
symptoms. 
4. Discussion 
In the first previous study (HKCTR-1128), Tianjiu Therapy has shown substan-
tial improvements in the medication need after treatment, included the number 
of symptoms which frequency appeared in asthma patients, and the number of 
days with asthma-related symptoms. There was nothing different between Tian-
jiu Therapy group and placebo group after the 3rd treatment immediately, but  
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Table 16. Efficacy observation on Tianjiu therapy for asthma. 
No. (%) Baseline The 1st course The 2nd course The 3rd course P value 
Q1:In the past 4 weeks, how much of the time did your asthma keep you from  
getting as much done at work, school or at home? 
All the time 0 2 1.1 1.1 
0.62 
Most of the time 18.2 4.1 4.1 4.4 
Some of the time 0 8.2 8.2 9.9 
A little of the time 9.1 8.2 8.2 12.1 
None of the time 72.7 77.6 77.6 72.5 
Q2: During the past 4 weeks, how often have you had shortness of the breath? 
All the time 9.1 6.1 3.3 7.7 
0.80 
Most of the time 18.2 16.3 11 8.8 
Some of the time 9.1 10.2 13.2 9.9 
A little of the time 18.2 20.4 34.1 27.5 
None of the time 45.5 46.9 38.5 46.2 
Q3: During the past 4 weeks, how often did you asthma symptoms  
(wheezing, coughing, shortness of breath, chest tightness or pain)  
wake you up at night or earlier than usual in the morning? 
All the time 0 8.2 4.4 13.2 
0.56 
Most of the time 18.2 4.1 7.7 5.5 
Some of the time 9.1 8.2 12.1 6.6 
A little of the time 9.1 20.4 17.6 16.5 
None of the time 63.6 59.2 58.2 58.2 
Q4: During the past 4 weeks, how often have you used your rescue inhaler or  
nebulizer medication (such as albuterol)? 
All the time 9.1 8.2 11 11 
0.72 
Most of the time 18.1 30.6 15.4 23.1 
Some of the time 9.1 2 6.6 9.9 
A little of the time 18.2 14.3 16.5 9.9 
None of the time 45.5 44.9 50.5 46.2 
Q5: How would you rate your asthma control during the past 4 weeks? 
All the time 0 0 2.2 1.1 
0.83 
Most of the time 9.1 6.1 6.6 7.7 
Some of the time 36.4 18.4 26.4 24.2 
A little of the time 45.5 49 46.7 53.8 
None of the time 9.1 26.5 18.7 13.2  
Total: The average total scores of 5 questions above. 
 19.55 ± 4.87 21.55 ± 1.37 20.91 ± 3.48 21.00 ± 2.93 0.427 
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the effect of Tianjiu Therapy has increasing trend than placebo group in the 
four-time followup; In the second previous study, it had proved that both 
2-course Tianjiu Therapy and one-course Tianjiu Therapy significantly reduced 
the number of symptoms which frequently appeared in asthma patients and me-
dication need in participants with chronic asthma as compared with baseline. 
The 2nd course Tianjiu Therapy was less sensitive than the first course Tianjiu 
Therapy for chronic asthma, however, the second course treatment still plays a 
role in solidating the curative effect of Tianjiu Therapy in the treatment of asth-
ma. Therefore, this study aimed to explore the efficiency if would get better as 
the courses get longer for asthma patients of Tianjiu Therapy in Sanfu days and 
tried to explore the optimal efficiency course. As a result, participants with 
asthma who received Tianjiu therapy in Sanfu days have improved with the days 
for asthma attack, asthma related process when asthma attacked including In-
ter-grated Chinese medicine and Western Medicine Clinic admitted, times of 
Inter-grated Chinese medicine and Western Medicine Clinic admitted, times of 
solving by own medicine and persistent medicine, and the symptom of waking 
up by asthma symptoms, lassitude, lacking of strength similarly in 3 courses 
compared with no treatment (All P < 0.05), these results showed that as the 
course get longer, the efficiency did not become better, instead, efficiency kept a 
stable status; the frequency of asthma attacked was much more improved in the 
2nd course and the 3rd course than in the 1st course (All P < 0.05), it means the ef-
ficiency kept a stable improvement in the 2nd course and the 3rd course; in some 
results like admitted to the hospital, solved by persistent medication when asth-
ma attack, the frequency of Chinese herbal medicine, and asthma was under 
controlled were improved in the 2nd course and the 3rd course; in some results 
like admitted to A & E, other treatment except bronchodilator and Chinese 
medicine and Western Medicine were improved in the 3rd course; and the fre-
quency of bronchodilator used was improved better in the 2nd course than the 1st 
course (P < 0.05). All above showed that as the course get longer, more symp-
toms were improved. And because the time points were chosen 1 year after 
Tianjiu Therapy, it proved that the efficiency was last for almost 1 year. But the 
symptoms of spleen-qi-deficient included spontaneous sweating, reduce of exer-
cise, diarrhea after intake of oily food were not improved as the course get long-
er. One of lung-qi-deficient symptoms like rapid or difficult breathing was im-
proved better in the 1st course than in the 2nd course and the 3rd course. The last 
but not the least, no changes occurred in pulmonary function and ACT for 3 
course compared with baseline, but have increasing trend in total score for ACT. 
5. Conclusion 
From the result of this study, although the symptoms of spleen-qi-deficient in-
cluding spontaneous sweating, reduce of exercise, diarrhea after intake of oily 
food were not improved as the course get longer, most symptoms other than that 
were improved when the course get longer. The results suggest that patients with 
chronic asthma who were receiving Tianjiu Therapy in Sanfu Days consecutively 
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for three years can be benefited better. 
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